Of note, astrocytic tumors without IDH mutation previously graded as WHO grade II were suggested to be denoted as glioblastoma WHO grade IV in the presence of either a TERT mutation, EGFR amplification, or + 7/− 10 chromosome copy number changes according to the recent cIMPACT-NOW update2. This evidence concerns the gene EGFR and glioblastoma.